Pain Management Billing in 2026: Interventional Procedures, Prior Auth, and Modifier Compliance

Published May 20, 2026 · 12 min read · By RCMAXIS Revenue Cycle Team

Pain management is one of the most prior-authorization-intensive specialties in medicine. The AMA's 2025 Prior Authorization Physician Survey found that pain management physicians face the highest rate of procedure denials on initial submission — with 28% of interventional procedures denied on the first request, requiring peer-to-peer review or appeal before authorization is granted. Add in the complexity of imaging guidance billing, place-of-service rules, and federally mandated drug testing documentation requirements, and it becomes clear why pain practices without specialized billing support consistently leave 12–18% of earned revenue uncollected.

At RCMAXIS, we bill for interventional pain practices, anesthesiology-based pain programs, and spine centers. Here is what our team monitors most closely for pain management billing accuracy.

1. Epidural Steroid Injections: Approach and Imaging Guidance

Epidural steroid injection (ESI) coding is determined by two variables: the approach (interlaminar vs. transforaminal) and the spinal region (cervical/thoracic vs. lumbar/sacral). Imaging guidance — fluoroscopy or CT — is separately reportable but governed by strict "with imaging guidance" vs. "without" code designation.

Epidural Injection Code Reference

• 62320: Injection, interlaminar, cervical or thoracic, without imaging guidance
• 62321: Injection, interlaminar, cervical or thoracic, with imaging guidance (fluoroscopy or CT)
• 62322: Injection, interlaminar, lumbar or sacral, without imaging guidance
• 62323: Injection, interlaminar, lumbar or sacral, with imaging guidance
• 64479: Injection, transforaminal, cervical or thoracic, single level
• 64480: Transforaminal, cervical or thoracic, each additional level (add-on)
• 64483: Injection, transforaminal, lumbar or sacral, single level
• 64484: Transforaminal, lumbar or sacral, each additional level (add-on)

When using a code that includes imaging guidance (62321, 62323), do not separately bill 77003 (fluoroscopic guidance). The guidance is already included. The "without" codes (62320, 62322) allow 77003 to be billed separately — but verify that fluoroscopy was actually used and documented, as billing 77003 without evidence of its use is a compliance risk.

2. Facet Joint Injections and Medial Branch Blocks

Facet joint injections (intra-articular) and medial branch nerve blocks are coded by spinal region and the number of levels. A common error is billing a medial branch block as a facet joint injection — they are distinct services with different codes and different prior authorization requirements at many payers.

Facet and Medial Branch Code Reference

• 64490: Injection, paravertebral facet joint or medial branch nerve, cervical or thoracic, single level
• 64491: Second level, cervical or thoracic (add-on)
• 64492: Third and any additional level, cervical or thoracic (add-on)
• 64493: Injection, paravertebral facet joint or medial branch nerve, lumbar or sacral, single level
• 64494: Second level, lumbar or sacral (add-on)
• 64495: Third and any additional level, lumbar or sacral (add-on)

Bilateral facet injections at the same level require modifier 50 (or two lines with the second line using modifier 50, depending on payer). Most payers limit medial branch blocks to two diagnostic blocks before authorizing radiofrequency ablation — document which injection session is first vs. second diagnostic block in your notes.

3. Radiofrequency Ablation (RFA)

Radiofrequency ablation of medial branch nerves for facet-mediated pain is one of the highest-value procedures in pain management, and one of the most closely scrutinized by payers. Most commercial payers and Medicare require documented failure of two medial branch blocks with at least 50–80% temporary pain relief before authorizing RFA.

RFA Code Reference

• 64633: Destruction by neurolytic agent, paravertebral facet joint nerve, cervical or thoracic, single level
• 64634: Each additional level, cervical or thoracic (add-on)
• 64635: Destruction by neurolytic agent, lumbar or sacral, single level
• 64636: Each additional level, lumbar or sacral (add-on)

RFA Prior Auth Documentation Checklist

• Documentation of two prior medial branch blocks with ≥50% pain relief (payer-specific threshold — some require 80%)
• Dates of both diagnostic blocks and percentage of relief documented at each
• Functional improvement at time of each block (pain diary, functional assessment score)
• Conservative care failure documentation (PT, medications, duration)
• MRI or X-ray supporting facet-mediated pain etiology

4. Spinal Cord Stimulator Trial and Implant

Spinal cord stimulation (SCS) involves a two-stage process — a trial period followed by permanent implantation — each with distinct billing codes and authorization requirements. The trial must demonstrate efficacy (typically 50%+ pain reduction and functional improvement) before payers will authorize the permanent implant.

SCS Code Reference

• 63650: Percutaneous implantation of neurostimulator electrode array, epidural — trial lead placement
• 63685: Insertion or replacement of spinal neurostimulator pulse generator or receiver, direct or inductive coupling — permanent generator
• 63688: Revision or removal of implanted spinal neurostimulator electrode array
• 95971: Electronic analysis of implanted neurostimulator pulse generator — simple (no reprogramming)
• 95972: Electronic analysis with complex reprogramming

5. Drug Testing in Pain Management

Urine drug testing is a federally mandated component of chronic opioid therapy monitoring in pain management. Since 2017, CMS has grouped drug testing codes by testing method — presumptive (immunoassay) vs. definitive (chromatography/mass spectrometry) — rather than by individual drug panels.

Drug Testing Code Reference

• 80305: Drug test(s), presumptive, any number of drug classes, read by direct optical observation — simple dipstick, per encounter
• 80306: Drug test(s), presumptive, by instrument-assisted direct optical observation — automated immunoassay reader
• 80307: Drug test(s), presumptive, by instrument chemistry analyzers using immunoassay or enzyme assay
• G0480–G0483: Definitive drug testing by liquid or gas chromatography-mass spectrometry (LC-MS/GC-MS), by number of drug classes (1–7, 8–14, 15–21, 22+)

Bill presumptive testing and definitive testing separately on the same date of service when both are performed — they are not bundled. However, document the clinical reason for definitive testing when presumptive results are negative or inconsistent with the patient's medication regimen, as payers increasingly require medical necessity documentation for confirmatory testing.

6. Place of Service: Office vs. ASC vs. Hospital Outpatient

Pain management reimbursement varies significantly by place of service. The same ESI procedure reimbursed at $350 in an office setting (POS 11) pays $220 in a hospital outpatient department (POS 22) when billed under the facility rate — a 37% difference. Understanding these differentials is critical for practice financial planning and for ensuring your claims reflect the correct POS code.

POS Billing Rules for Pain Management

• Use POS 11 (office) when performing procedures in your own procedure suite — you receive both the professional and facility component
• Use POS 22 (hospital outpatient) when operating in a hospital-based procedure suite — the hospital bills the facility fee; you bill only the professional component
• Use POS 24 (ambulatory surgical center) for procedures performed in a free-standing ASC — the ASC bills the facility; you bill the professional fee
• POS mismatch is a compliance trigger — the POS on your professional claim must match the setting where the procedure was actually performed

RCMAXIS's pain management billing team manages prior authorization tracking, procedure documentation review, and denial appeal workflows for interventional practices. Our claims management process includes a pre-submission auth verification step that catches missing or expired authorizations before the claim goes out — eliminating the most common source of pain management denials.